Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
NCT ID: NCT01498458
Description: None
Frequency Threshold: 5
Time Frame: 24 months
Study: NCT01498458
Study Brief: Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pazopanib Plus Capecitabine There was only one arm in this study as this was a dose escalation study. None None 6 8 8 8 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hepatotoxicity SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (10.0) View
Hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (10.0) View
Pancreatectomy NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (10.0) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (10.0) View
anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (10.0) View
ASAT SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (10.0) View
Bilirubinaemia SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (10.0) View
Fatigue CTC grade 3 SYSTEMATIC_ASSESSMENT General disorders MedDRA (10.0) View
Mucositis CTC grade 3 SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
Hand-foot syndrome SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (10.0) View
alkaline Phosphatase SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (10.0) View
Nausea CTC grade 3 SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (10.0) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (10.0) View